Form4insider filings, from the source

Insider holders · CIK 0001743881

BridgeBio Pharma, Inc. · BBIO

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Neil KumarChief Executive Officer243,327750,000993,327Sep 21, 2026 · 6:21 pm EDTForm 4
Charles J HomcyDirector919,876—919,876Jun 24, 2026 · 6:06 pm EDTForm 4
Frank McCormickDirector10,579756,665767,244Jun 24, 2026 · 6:05 pm EDTForm 4
Thomas TrimarchiPresident and CFO336,529—336,529Aug 18, 2026 · 6:02 pm EDTForm 4
Ali J. SatvatDirector169,983—169,983Jun 24, 2026 · 6:05 pm EDTForm 4
Maricel ApuliChief Accounting Officer122,687—122,687Aug 18, 2026 · 6:02 pm EDTForm 4
James C MomtazeeDirector19,07080,00099,070Jun 24, 2026 · 6:05 pm EDTForm 4
Andrew LoDirector18,07950,58368,662Jun 24, 2026 · 6:06 pm EDTForm 4
Douglas A. DachilleDirector10,57920,00030,579Jun 24, 2026 · 6:05 pm EDTForm 4
Fred HassanDirector29,879—29,879Jun 24, 2026 · 6:05 pm EDTForm 4
Andrea EllisDirector22,579—22,579Jul 13, 2026 · 4:41 pm EDTForm 4
Ronald J DanielsDirector20,981—20,981Jun 24, 2026 · 6:05 pm EDTForm 4
Eric AguiarDirector10,579—10,579Jun 24, 2026 · 6:06 pm EDTForm 4
Hannah ValantineDirector9,2593989,657Jun 24, 2026 · 6:06 pm EDTForm 4
Jennifer E. CookDirector8,383—8,383Jul 13, 2026 · 4:40 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.